Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2008, p. 1952-1956, Vol. 52, No. 6
0066-4804/08/$08.00+0 doi:10.1128/AAC.01463-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Characterization of a Naturally Occurring Class D β-Lactamase from Achromobacter xylosoxidans
Yohei Doi,1,2
Laurent Poirel,1
David L. Paterson,2,3 and
Patrice Nordmann1*
Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, 94275 K.-Bicêtre, France,1
Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania,2
University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia3
Received 12 November 2007/
Returned for modification 2 February 2008/
Accepted 16 March 2008

ABSTRACT
A chromosomally encoded class D β-lactamase, OXA-114, was
characterized from
Achromobacter xylosoxidans strain CIP69598.
β-Lactamase OXA-114 shared 56% amino acid identity with
the naturally occurring class D β-lactamase of
Burkholderia cenocepacia and 42% identity with the acquired oxacillinases
OXA-9 and OXA-18. OXA-114 has a narrow-spectrum hydrolysis profile,
although it includes imipenem, at a very low level. PCR and
sequencing revealed that
blaOXA-114-like genes were identified
in all
A. xylosoxidans strains tested (
n = 5), indicating that
this β-lactamase is naturally occurring in that species.
Induction experiments with imipenem and cefoxitin did not show
inducibility of
blaOXA-114 expression.

INTRODUCTION
Achromobacter xylosoxidans (previously
Alcaligenes xylosoxidans)
is a non-glucose-fermenting gram-negative species that is increasingly
recognized as a clinically significant nosocomial pathogen.
With its tendency to contaminate fluid, many outbreaks have
been reported, mostly in immunocompromised hosts, causing serious
infections, including bacteremia (
4,
9). The organism has variable
susceptibility to β-lactams (
8). It is mostly resistant
to narrow-spectrum penicillins and to several cephalosporins,
including cefotaxime, whereas susceptibility to ureidopenicillins
and carbapenems varies (
8). However, acquisition of metallo-β-lactamases,
such as IMP-1, VIM-1, or VIM-2, has been reported for
A. xylosoxidans,
therefore leading to high-level resistance to carbapenems (
12,
17-
20).
The intrinsic β-lactamases produced by A. xylosoxidans have been characterized only biochemically. Lévesque et al. reported three types of cephalosporinases, with isoelectric points (pIs) of 7.4, 9.3, and 8.1 and molecular masses of 32.3 kDa, 22.800 kDa, and 36.200 kDa, respectively (13). Fujii et al. characterized a penicillinase with an unusually high pI of 9.8 and a molecular mass of 18 kDa (5). Philippon et al. reported a penicillinase with a pI of 5.7 and an oxacillinase with a pI of 7.7 (3, 15). None of the β-lactamase genes have been identified so far. The present study was designed to identify and to characterize, at the genetic and biochemical levels, the naturally occurring β-lactamase(s) of A. xylosoxidans.

MATERIALS AND METHODS
Bacterial strains and plasmids.
A. xylosoxidans reference strain CIP69598 (Pasteur Institute
strain collection) and four clinical isolates recovered at the
Bicêtre hospital (MER, TB1, LOL, and DUC) were included
in the study. Identification was performed with the API 32-GN
system (bioMerieux, Marcy l'Etoile, France).
Escherichia coli TOP10 (Invitrogen, Cergy Pontoise, France) was used as the host
for cloning experiments. Kanamycin-resistant pBK-CMV plasmid
(Stratagene, Amsterdam, The Netherlands) was used as the cloning
vector. Bacterial cultures were routinely grown in Trypticase
soy (TS) broth at 37°C.
Antimicrobial agents and susceptibility testing.
MICs of various β-lactams were determined by an agar dilution technique, as previously described (16). Results of susceptibility testing were interpreted according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) (1).
Cloning experiments and analysis of recombinant plasmids.
Genomic DNA from A. xylosoxidans CIP69598 was extracted and digested partially with restriction enzyme Sau3AI (New England Biolabs, Ipswich, MA). The resultant DNA fragments were ligated with BamHI-digested pBK-CMV as described previously (16). E. coli strain TOP10 was transformed with these recombinant plasmids by electroporation (Gene Pulser II; Bio-Rad Laboratories, Ivry-sur-Seine, France). Transformants were selected on TS agar containing ticarcillin (50 mg/liter) and kanamycin (30 mg/liter). The recombinant plasmid was purified with a Qiagen plasmid mini kit (Qiagen, Courtaboeuf, France) and sequenced on both strands by use of an ABI 3100 sequencer (Applied Biosystems, Foster City, CA). The nucleotide and deduced protein sequences were analyzed with software available over the Internet (www.ncbi.nlm.nih.gov).
Genotyping comparison of the five A. xylosoxidans isolates was performed using the random amplified polymorphic DNA detection technique as described previously (21).
PCR experiments and genotyping.
The blaOXA genes of the studied strains were amplified by use of external primers OXA-114A (5'-ACGCCTGAACCCTTTTATCC-3') and OXA-114B (5'-ATCGACAGGCCGCGCAGT-3') to produce a 1,025-bp fragment. Both strands of the PCR products were then sequenced.
IEF analysis and hydrolytic and induction studies.
Isoelectric focusing (IEF) analysis was performed with a pH 3.5 to 9.5 Ampholine polyacrylamide gel (GE Healthcare), using crude extracts of the A. xylosoxidans isolates and of E. coli TOP10 harboring p6S3 (16). The inducibility of β-lactamase production in A. xylosoxidans isolates CIP69598 and LOL was tested in TS broth at 37°C, using imipenem (1 µg/ml) and cefoxitin (50 µg/ml) as inducers, as described previously (11), and hydrolysis was measured with 100 µM of benzylpenicillin or imipenem as the substrate. The β-lactamase activity was defined as follows: 1 unit of enzyme was the amount that hydrolyzed 1 µmol of substrate per min. The total protein content was measured with bovine albumin as the standard (DC protein assay kit; Bio-Rad).
β-Lactamase purification.
The β-lactamase was purified as previously described, with some modifications (11). E. coli TOP10(p6S3) was cultured overnight in 4 liters of TS broth containing 30 µg/ml of kanamycin and 50 µg/ml of ampicillin. After centrifugation, the bacterial pellet was resuspended in 30 ml of 100 mM phosphate buffer (pH 7.0). Crude protein extracts were then obtained by sonication followed by centrifugation. After spermine treatment for precipitation of DNA, the supernatant was subjected to several purification steps, including ion-exchange chromatography with a Q-Sepharose column, first with 20 mM Tris-HCl buffer (pH 8.8), followed by chromatography on an S-Sepharose column equilibrated with 20 mM bis-Tris buffer (pH 6.5). Elution of the β-lactamase was performed with a linear K2SO4 gradient (0 to 500 mM). Peaks of β-lactamase activity were pooled and dialyzed against 50 mM phosphate buffer (pH 7.0). The protein content was measured by the Bio-Rad DC protein assay, and the specific activities of the crude extract and the purified β-lactamase from E. coli TOP10(p6S3) were compared. The protein purification rate and the relative molecular mass of β-lactamase OXA-114a were estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Kinetic studies.
Purified β-lactamase was used for determination of kinetic parameters (kcat and Km) at 30°C in a reaction buffer made of 100 mM Tris-H2SO4-300 mM K2SO4 (pH 7.0), in which NaHCO3 was added to a final concentration of 10 mM in order to avoid biphasic kinetics (14). The initial rates of hydrolysis of β-lactams were determined with a UV spectrophotometer as previously described (10). Due to a too-low Km value for piperacillin, a Ki value was obtained by competition, using benzylpenicillin as a reporter substrate. The 50% inhibitory concentration was determined as the clavulanate, tazobactam, or sulbactam concentration that reduced the hydrolysis rate of 100 µM of cephalothin by 50% under conditions in which the enzyme was preincubated with various concentrations of inhibitor for 3 min at 30°C before addition of the substrate.
Nucleotide sequence accession number.
The nucleotide sequences for OXA-114a reported in this paper have been submitted to the EMBL/GenBank nucleotide sequence database under accession number EU188842.

RESULTS AND DISCUSSION
β-Lactam resistance phenotypes of study strains.
The five studied
A. xylosoxidans strains were resistant to cefotaxime,
cefoxitin, cefepime, and aztreonam, as usually observed in that
species. They were susceptible to piperacillin, moxalactam,
and imipenem according to the CLSI criteria (Table
1). Susceptibility
to ticarcillin and ceftazidime was variable, with resistance
to those β-lactam molecules being observed only for strains
LOL and MER. Although all isolates were susceptible to imipenem,
various MICs were obtained (Table
1). Since such a phenomenon
might have resulted from variable expression of a carbapenemase,
imipenem hydrolysis was measured and showed weak interstrain
variability, with 3, 5, and 12 mU per mg of protein for isolates
CIP, MER, and LOL, respectively, without a correlation with
the MICs of imipenem (Table
1). IEF analysis revealed an identical
pI value of 8.6 obtained with cultures of each isolate. Two
other bands were also detected for those isolates, with pI values
of approximately 5.5 and 9.5.
View this table:
[in this window]
[in a new window]
|
TABLE 1. MICs of β-lactams for A. xylosoxidans strain CIP69598, E. coli TOP10 harboring recombinant plasmid p6S3, expressing the β-lactamase OXA-114a, and E. coli TOP10 (reference strain)
|
Cloning and sequencing of the β-lactamase gene.
Repeated cloning experiments yielded only a single
E. coli clone
after selection on ticarcillin- and kanamycin-containing plates.
Recombinant strain
E. coli TOP10(p6S3) possessed a 1,176-bp
plasmid insert and was resistant to amoxicillin and piperacillin,
a resistance pattern which was not inhibited by clavulanic acid
and tazobactam, respectively (Table
1). Sequencing of plasmid
p6S3 revealed an open reading frame consisting of 828 bp, corresponding
to a 275-amino-acid protein. Sequence analysis indicated that
this open reading frame corresponded to a novel class D β-lactamase.
The closest identity was observed with putative naturally occurring
β-lactamases of
Burkholderia cenocepacia and
Delftia acidovorans,
with up to 50% amino acid sequence identity (GenBank accession
no. ABK10118.1 and EAV77675.1, respectively) and 37% identity
with the acquired oxacillinases OXA-9 and OXA-18 (Fig.
1) (
16,
22). This novel β-lactamase from
A. xylosoxidans was designated
OXA-114a (since other variants were subsequently identified)
(see below). OXA-114a possessed the conserved motifs of serine
β-lactamases, such as S-T-F-K at positions 70 to 73 and
the K-T-G motif at positions 216 to 218, according to the class
D β-lactamase numbering scheme (
2). The Y-G-N and Q-X-X-X-L
motifs, characteristic of an oxacillinase, were identified at
positions 144 to 146 and 176 to 180, respectively. The pI value
of the mature OXA-114a protein was 8.6, and its molecular mass
was ca. 27 kDa.
Detection of OXA-114-like β-lactamase genes in A. xylosoxidans isolates.
Four additional
A. xylosoxidans isolates were screened for the
presence of
blaOXA-114a. Preliminary random amplified polymorphic
DNA genotyping showed that the five strains were not clonally
related (data not shown). PCR amplification performed with primers
specific for
blaOXA-114a yielded amplicons from all the studied
strains. Sequencing identified four other OXA-114-like sequences
(OXA-114b to OXA-114e) sharing high amino acid identity, with
a maximum four-amino-acid difference between each other. None
of the variable residues were located in conserved sequences
typical of oxacillinases (Fig.
2).
Kinetic parameters of OXA-114a.
After purification, the purity of the OXA-114a extract was estimated
to be >90% by sodium dodecyl sulfate-polyacrylamide gel electrophoresis,
with a yield of 250 µg per liter of culture. The purification
coefficient was estimated to be 35-fold. Kinetic measurements
of purified OXA-114a indicated an overall weak catalytic efficiency
toward β-lactams. However, efficient hydrolysis of piperacillin
and, to a lesser extent, ticarcillin was noticed (Table
2).
Oxacillin hydrolysis was not detected with OXA-114a, as previously
observed for other oxacillinases, such as the naturally occurring
OXA-50 from
Pseudomonas aeruginosa (
6). No hydrolysis was detected
for expanded-spectrum cephalosporins, such as ceftazidime, cefoxitin,
and cefepime. Thus, the resistance observed for the last two
substrates in all the clinical isolates was likely not related
to the β-lactamase OXA-114. Interestingly, a detectable
hydrolysis of imipenem was observed. However,
kcat values could
not be obtained for imipenem because of a very high
Km value
(>2,000 µM), indicating a very poor affinity for that
substrate. Hydrolysis of imipenem by OXA-114a was in accordance
with the hydrolysis of that substrate determined with culture
extracts obtained from the clinical isolates. This result suggested
that this β-lactamase could be expressed in those isolates,
even at a low level. As observed for most oxacillinases, β-lactamase
OXA-114a was not inhibited by class A β-lactamase inhibitors.
Induction experiments.
Using imipenem and cefoxitin as inducers, no significant increase
in hydrolysis was noticed for both benzylpenicillin and imipenem
as substrates, likely indicating that expression of OXA-114
was not inducible. This result fits with the lack of induction
of many naturally occurring oxacillinases, as observed for OXA-50
in
P. aeruginosa (
6) or OXA-51/69 in
Acinetobacter baumannii (
11), whereas inducibility of oxacillinase OXA-60 from another
gram-negative aerobe,
Ralstonia pickettii, was observed (
7).
Conclusions.
This study contributed to unraveling at least one of the natural mechanisms of resistance to β-lactams in A. xylosoxidans. This work identified the naturally occurring β-lactamase of A. xylosoxidans as being neither a penicillinase nor a cephalosporinase, as previously suggested (5, 13), but rather a narrow-spectrum class D β-lactamase. It is likely that the contribution of OXA-114-like enzymes to the final β-lactam resistance profile of most A. xylosoxidans strains may be secondary, as previously demonstrated for naturally occurring oxacillinases of other gram-negative aerobic species, such as OXA-50-like enzymes from P. aeruginosa or OXA-51/69 from A. baumannii. However, since it is known that expression of that latter β-lactamase gene could be enhanced by the presence of insertion sequence elements providing promoter sequences (ISAba1 in A. baumannii), it might be hypothesized that similar events could also be expected for blaOXA-114-like genes in A. xylosoxidans, leading to a higher level of OXA-114-mediated β-lactam resistance. The present study strengthens the observation that numerous gram-negative aerobes harbor naturally occurring class D β-lactamase genes in their chromosomes and constitute possible sources of resistance genes.

ACKNOWLEDGMENTS
We thank H. Mammeri, A. Carrër, and G. Cuzon for technical
help.
This work was funded by a grant from the Ministère de l'Education Nationale et de la Recherche (UPRES-EA3539), Université Paris XI, Paris, France, and mostly by a grant from the European Community (LSHM-CT-2005-018705). Y.D. was funded in part by NIH training grant T32AI007333.

FOOTNOTES
* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail:
nordmann.patrice{at}bct.aphp.fr 
Published ahead of print on 24 March 2008. 

REFERENCES
1 - Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
2 - Couture, F., J. Lachapelle, and R. C. Lévesque. 1992. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol. Microbiol. 6:1693-1705.[Medline]
3 - Decré, D., G. Arlet, E. Bergogne-Bérézin, and A. Philippon. 1995. Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans. Antimicrob. Agents Chemother. 39:771-774.
4 - Duggan, J. M., S. J. Goldstein, C. E. Chenoweth, C. A. Kauffman, and S. F. Bradley. 1996. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin. Infect. Dis. 23:569-576.[Medline]
5 - Fujii, T., K. Sato, M. Inoue, and S. Mitsuhashi. 1985. Purification and properties of a β-lactamase from Alcaligenes denitrificans subsp. xylosoxydans. J. Antimicrob. Chemother. 16:297-304.[Abstract/Free Full Text]
6 - Girlich, D., T. Naas, and P. Nordmann. 2004. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:2043-2048.[Abstract/Free Full Text]
7 - Girlich, D., T. Naas, and P. Nordmann. 2004. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D β-lactamase from Ralstonia pickettii. Antimicrob. Agents Chemother. 48:4217-4225.[Abstract/Free Full Text]
8 - Glupczynski, Y., W. Hansen, J. Freney, and E. Yourassowsky. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob. Agents Chemother. 32:276-278.[Abstract/Free Full Text]
9 - Gomez-Cerezo, J., I. Suarez, J. J. Rios, P. Pena, M. J. Garcia de Miguel, M. de Jose, O. Monteagudo, P. Linares, A. Barbado-Cano, and J. J. Vazquez. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur. J. Clin. Microbiol. Infect. Dis. 22:360-363.[CrossRef][Medline]
10 - Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.[Abstract/Free Full Text]
11 - Héritier, C., L. Poirel, P. E. Fournier, J. M. Claverie, D. Raoult, and P. Nordmann. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179.[Abstract/Free Full Text]
12 - Iyobe, S., H. Kusadokoro, A. Takahashi, S. Yomoda, T. Okubo, A. Nakamura, and K. O'Hara. 2002. Detection of a variant metallo-β-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans strain. Antimicrob. Agents Chemother. 46:2014-2016.[Abstract/Free Full Text]
13 - Lévesque, R., R. Letarte, and J. C. Pechère. 1983. Comparative study of the β-lactamase activity found in Achromobacter. Can. J. Microbiol. 29:819-826.[Medline]
14 - Maveyraud, L., D. Golemi, L. P. Kotra, S. Tranier, S. Vakulenko, S. Mobashery, and J. P. Samama. 2000. Insights into class D β-lactamases are revealed by the crystal structure of the OXA-10 enzyme from Pseudomonas aeruginosa. Structure 8:1289-1298.[Medline]
15 - Philippon, A., K. Mensah, G. Fournier, and J. Freney. 1990. Two resistance phenotypes to β-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to β-lactamase types. J. Antimicrob. Chemother. 25:698-700.[Free Full Text]
16 - Philippon, L. N., T. Naas, A. T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2188-2195.[Abstract]
17 - Riccio, M. L., L. Pallecchi, R. Fontana, and G. M. Rossolini. 2001. In70 of plasmid pAX22, a blaVIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45:1249-1253.[Abstract/Free Full Text]
18 - Senda, K., Y. Arakawa, S. Ichiyama, K. Nakashima, H. Ito, S. Ohsuka, K. Shimokata, N. Kato, and M. Ohta. 1996. PCR detection of metallo-β-lactamase gene blaIMP in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.[Abstract]
19 - Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41:5407-5413.[Abstract/Free Full Text]
20 - Sofianou, D., A. Markogiannakis, E. Metzidie, S. Pournaras, and A. Tsakris. 2005. VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 24:854-855.[CrossRef][Medline]
21 - Telenius, H., N. P. Carter, C. E. Bebb, M. Nordenskjöld, B. A. Ponder, and A. Tunnacliffe. 1992. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718-725.[CrossRef][Medline]
22 - Tolmasky, M. E. 1990. Sequencing and expression of aadA, bla, and tnpR from the multiresistance transposon Tn1331. Plasmid 24:218-226.[CrossRef][Medline]
Antimicrobial Agents and Chemotherapy, June 2008, p. 1952-1956, Vol. 52, No. 6
0066-4804/08/$08.00+0 doi:10.1128/AAC.01463-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.